Latest Enzyme Stories
A long-used anti-cancer drug could be a starting point to develop new treatments for the incurable nerve disease known as Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), scientists are reporting.
What’s good news in one setting might spell disaster in another.
Researchers at the University of Gothenburg, Sweden, are working to develop substances that can prevent parasites, bacteria and fungi from producing essential proteins, research that could, in the long term, lead to new drugs for several major diseases.
Scientists at The Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body.
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified key elements in the biochemical mechanism plants use to limit the production of fatty acids.
For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not.
Chalcone-isomerase protein holds much promise of economic benefit
Now available from Swanson Health Products: Stimulant free Swanson Ultra ZIP EX2 Enzymatic Energizer featuring digestive enzymes, natural herbs and specific vitamins to provide long lasting energy
The latest episode in the American Chemical Society’s (ACS’) award-winning Global Challenges/Chemistry Solutions podcast series focuses on adaptation of the ubiquitous personal glucose monitor, typically used to test blood sugar levels, for possible home use in testing for viruses and bacteria in human body fluids, food and other substances.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.